Mechanisms of metastatic colorectal cancer
- PMID: 38806657
- DOI: 10.1038/s41575-024-00934-z
Mechanisms of metastatic colorectal cancer
Abstract
Despite extensive research and improvements in understanding colorectal cancer (CRC), its metastatic form continues to pose a substantial challenge, primarily owing to limited therapeutic options and a poor prognosis. This Review addresses the emerging focus on metastatic CRC (mCRC), which has historically been under-studied compared with primary CRC despite its lethality. We delve into two crucial aspects: the molecular and cellular determinants facilitating CRC metastasis and the principles guiding the evolution of metastatic disease. Initially, we examine the genetic alterations integral to CRC metastasis, connecting them to clinically marked characteristics of advanced CRC. Subsequently, we scrutinize the role of cellular heterogeneity and plasticity in metastatic spread and therapy resistance. Finally, we explore how the tumour microenvironment influences metastatic disease, emphasizing the effect of stromal gene programmes and the immune context. The ongoing research in these fields holds immense importance, as its future implications are projected to revolutionize the treatment of patients with mCRC, hopefully offering a promising outlook for their survival.
© 2024. Springer Nature Limited.
Similar articles
-
Determinants of metastatic competency in colorectal cancer.Mol Oncol. 2017 Jan;11(1):97-119. doi: 10.1002/1878-0261.12018. Epub 2017 Jan 3. Mol Oncol. 2017. PMID: 28085225 Free PMC article. Review.
-
Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer.Int J Mol Sci. 2021 Feb 19;22(4):2067. doi: 10.3390/ijms22042067. Int J Mol Sci. 2021. PMID: 33669775 Free PMC article. Review.
-
Research progress on genetic heterogeneity between primary and paired metastatic colorectal cancer.Yi Chuan. 2017 Jun 20;39(6):482-490. doi: 10.16288/j.yczz.16-357. Yi Chuan. 2017. PMID: 28903907 Review.
-
The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.Front Immunol. 2021 Oct 6;12:724883. doi: 10.3389/fimmu.2021.724883. eCollection 2021. Front Immunol. 2021. PMID: 34691029 Free PMC article. Review.
-
Metastatic colorectal cancer: mechanisms and emerging therapeutics.Trends Pharmacol Sci. 2023 Apr;44(4):222-236. doi: 10.1016/j.tips.2023.01.003. Epub 2023 Feb 23. Trends Pharmacol Sci. 2023. PMID: 36828759 Free PMC article. Review.
Cited by
-
Bioengineered Tumor-Derived Extracellular Vehicles Suppressed Colorectal Cancer Liver Metastasis and Bevacizumab Resistance.Adv Sci (Weinh). 2025 Jun;12(23):e2417714. doi: 10.1002/advs.202417714. Epub 2025 May 21. Adv Sci (Weinh). 2025. PMID: 40397411 Free PMC article.
-
Targeting LINC02320 prevents colorectal cancer growth via GRB7-dependent inhibition of MAPK signaling pathway.Cell Mol Biol Lett. 2025 Jul 21;30(1):86. doi: 10.1186/s11658-025-00770-2. Cell Mol Biol Lett. 2025. PMID: 40691533 Free PMC article.
-
CD44 knockdown alters miRNA expression and their target genes in colon cancer.Front Immunol. 2025 May 14;16:1552665. doi: 10.3389/fimmu.2025.1552665. eCollection 2025. Front Immunol. 2025. PMID: 40438109 Free PMC article.
-
Cross-cohort multi-omics analysis identifies novel clusters driven by EMT signatures in colorectal cancer.Front Immunol. 2025 Jun 12;16:1628005. doi: 10.3389/fimmu.2025.1628005. eCollection 2025. Front Immunol. 2025. PMID: 40574852 Free PMC article.
-
Explainable multi-modal radiomics for early prediction of liver metastasis in rectal cancer: a multicentric study.Insights Imaging. 2025 Jun 27;16(1):142. doi: 10.1186/s13244-025-02010-9. Insights Imaging. 2025. PMID: 40579653 Free PMC article.